Health Condition 1: N943- Premenstrual tension syndrome
Conditions
Interventions
Intervention1: Brahmi (Centella asiatica): 2gm BD will be administered orally from day 16 of the menstrual cycle to day 5 of the next cycle for 3 consecutive cycles.
Control Intervention1: placebo(sta
Sponsors
National Institute of Unani Medicine
Eligibility
Inclusion criteria
Inclusion criteria: Women aged 15-49 years, have regular menstrual cycles of 21 to 35 days. Presenting with signs and symptoms of premenstrual syndrome (physical, psychological & social symptoms for at least 3 menstrual cycles, as per PSST scale (premenstrual syndrome screening tool)
Exclusion criteria
Exclusion criteria: Diagnosed cases of major psychological disorder. Women use anxiolytics, antidepressants, mood stabilizers, and sedatives within two months. Women with uncontrolled endocrine diseases (DM,Thyroid disorder). On OCPs and lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in PSST (premenstrual Symptom Screening Tool)Timepoint: Change in PSST (premenstrual Symptom Screening Tool) at baseline, 12th week and 16th week | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in VAS score and TSQM scale.Timepoint: Change in VAS score before and after treatment and TSQM scale after treatment | — |
Countries
India
Contacts
Public ContactArshiya Sultana
National Institute of Unani medicine
Outcome results
None listed